These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 3542279

  • 1. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
    Ashton JH, Schmitz JM, Campbell WB, Ogletree ML, Raheja S, Taylor AL, Fitzgerald C, Buja LM, Willerson JT.
    Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK, Ober JC, McNatt J, Benedict CR, Rosolowsky M, Anderson HV, Cui K, Maffrand JP, Campbell WB, Buja LM.
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P, Fukuhara M, Diz DI, Ferrario CM, Brosnihan KB.
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [Abstract] [Full Text] [Related]

  • 9. The effect of the thromboxane A2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion.
    Grover GJ, Schumacher WA, Simon M, Parham C.
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):701-9. PubMed ID: 2467089
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries.
    Ashton JH, Golino P, McNatt JM, Buja LM, Willerson JT.
    J Am Coll Cardiol; 1989 Mar 01; 13(3):755-63. PubMed ID: 2521875
    [Abstract] [Full Text] [Related]

  • 12. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
    Yao SK, Benedict CR, Rosolowsky M, McNatt J, Falinska B, Campbell WB, Buja LM, Willerson JT.
    J Mol Cell Cardiol; 1991 Apr 01; 23(4):473-82. PubMed ID: 1942081
    [Abstract] [Full Text] [Related]

  • 13. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes.
    Parent CA, Lagarde M, Venton DL, Le Breton GC.
    J Biol Chem; 1992 Apr 05; 267(10):6541-7. PubMed ID: 1532390
    [Abstract] [Full Text] [Related]

  • 14. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
    Yao SK, Rosolowsky M, Anderson HV, Golino P, NcNatt JM, De Clerck F, Buja LM, Willerson JT.
    J Am Coll Cardiol; 1990 Sep 05; 16(3):705-13. PubMed ID: 2143767
    [Abstract] [Full Text] [Related]

  • 15. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK, Mais DE, Halushka PV.
    Biochim Biophys Acta; 1994 Mar 10; 1221(1):83-8. PubMed ID: 8130280
    [Abstract] [Full Text] [Related]

  • 16. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors.
    Mais DE, Liel N, Halushka PV.
    Biochem Pharmacol; 1990 Oct 01; 40(7):1457-61. PubMed ID: 2145838
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE, Saussy DL, Chaikhouni A, Kochel PJ, Knapp DR, Hamanaka N, Halushka PV.
    J Pharmacol Exp Ther; 1985 May 01; 233(2):418-24. PubMed ID: 2987481
    [Abstract] [Full Text] [Related]

  • 18. Subcellular localization of a thromboxane A2/prostaglandin H2 receptor antagonist binding site in human platelets.
    Saussy DL, Mais DE, Baron DA, Pepkowitz SH, Halushka PV.
    Biochem Pharmacol; 1988 Feb 15; 37(4):647-54. PubMed ID: 2963640
    [Abstract] [Full Text] [Related]

  • 19. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
    Mais DE, Kochel PJ, Saussy DL, Halushka PV.
    Mol Pharmacol; 1985 Aug 15; 28(2):163-9. PubMed ID: 2991736
    [Abstract] [Full Text] [Related]

  • 20. The thromboxane A2 mimetic U46619 worsens canine myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis.
    Bache RJ, Dai XZ.
    Cardiovasc Res; 1992 Apr 15; 26(4):351-6. PubMed ID: 1638566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.